Carcinoma, Islet Cell - 25 Studies Found
Terminated |
: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery :
|
Active, not recruiting |
: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors :
|
Recruiting |
: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors :
|
Completed |
: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors :
|